DUOTRAV Trademark

Trademark Overview

On Monday, July 3, 2023, a trademark application was filed for DUOTRAV with the United States Patent and Trademark Office. The USPTO has given the DUOTRAV trademark a serial number of 79375867. The federal status of this trademark filing is REGISTERED as of Tuesday, March 12, 2024. This trademark is owned by Novartis AG. The DUOTRAV trademark is filed in the Pharmaceutical Products category with the following description:

Ophthalmic pharmaceutical preparations for the treatment of glaucoma
duotrav

General Information

Serial Number79375867
Word MarkDUOTRAV
Filing DateMonday, July 3, 2023
Status700 - REGISTERED
Status DateTuesday, March 12, 2024
Registration Number7324658
Registration DateTuesday, March 12, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 26, 2023

Trademark Statements

Goods and ServicesOphthalmic pharmaceutical preparations for the treatment of glaucoma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 18, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Tuesday, August 22, 2023APPLICATION FILING RECEIPT MAILED
Friday, August 4, 2023SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Tuesday, August 15, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, August 18, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 7, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 7, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 7, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, September 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 16, 2023ASSIGNED TO EXAMINER
Wednesday, December 6, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 26, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 26, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, March 12, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, May 6, 2024NOTIFICATION PROCESSED BY IB
Wednesday, January 1, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, January 1, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, January 17, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, April 11, 2024GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Friday, April 12, 2024FINAL DISPOSITION PROCESSED
Friday, April 12, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 4, 2025INTERNATIONAL REGISTRATION RENEWED

Related Keywords

duotrav glaucoma treatment preparations pharmaceutical ophthalmic